Prognostic influence of fibroblast growth factor 23 on the course of coronary heart disease in patients with chronic kidney disease | Samakaev | South Russian Journal of Therapeutic Practice

South Russian Journal of Therapeutic Practice

ISSN 2712-8156 (Print)

eng | рус

Preview

South Russian Journal of Therapeutic Practice

Advanced search

Archives

Download this PDF file

For citations:

Samakaev A.S., Glova S.E., Khaisheva L.A., Lapushkina M.A., Shlyk S.V. Prognostic influence of fibroblast growth factor 23 on the course of coronary heart disease in patients with chronic kidney disease. South Russian Journal of Therapeutic Practice. 2024;5(1):32-37. (In Russ.) https://doi.org/10.21886/2712-8156-2024-5-1-32-37

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2712-8156 (Print)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Chesnikova Anna I.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. S. Samakaev
Rostov State Medical University
Russian Federation

Azat S. Samakaev, postgraduate, Chair of Therapy

Rostov-on-Don

S. E. Glova
Rostov State Medical University
Russian Federation

Svetlana E. Glova, Cand. Sci. (Med.), Associate Professor, Chair of Therapy

Rostov-on-Don

L. A. Khaisheva
Rostov State Medical University
Russian Federation

Larisa A. Khaisheva, Dr. Sci. (Med.), Professor, Chair of Therapy

Rostov-on-Don

M. A. Lapushkina
Rostov State Medical University
Russian Federation

Marina A. Lapushkina, student

Rostov-on-Don

S. V. Shlyk
Rostov State Medical University
Russian Federation

Sergey V. Shlyk, Dr. Sci. (Med.), Professor, Chair of Therapy, Rector

Rostov-on-Don

Notifications